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Background: To review the possible mechanisms proposed to explain the etiology of 46, XX sex reversal
by investigating the clinical characteristics and their relationships with chromosomal karyotype and the
SRY(sex-determining region Y)gene.
Methods: Five untreated 46, XX patients with SRY-positive were referred for infertility. Clinical data were
collected, and Karyotype analysis of G-banding in lymphocytes and Fluorescence in situ hybridization (FISH)
were performed. Genomic DNA from peripheral blood of the patients using QIAamp DNA Blood Kits was extracted.
The three discrete regions, AZFa, AZFb and AZFc, located on the long arm of the Y chromosome, were performed by
multiplex PCRs(Polymerase Chain Reaction) amplification. The set of PCR primers for the diagnosis of microdeletion of
the AZFa, AZFb and AZFc region included: sY84, sY86, sY127, sY134, sY254, sY255, SRY and ZFX/ZFY.
Results: Our five patients had a lower body height. Physical examination revealed that their testes were small in
volume, soft in texture and normal penis. Semen analyses showed azoospermia. All patients had a higher
follicle-stimulating hormone(FSH), Luteinizing Hormone(LH) level, lower free testosterone, testosterone level
and normal Estradiol, Prolactin level. Karyotype analysis of all patients confirmed 46, XX karyotype, and FISH
analysis showed that SRY gene were positive and translocated to Xp. Molecular analysis revealed that the SRY
gene were present, and the AZFa, AZFb and AZFc region were absent.
Conclusions: This study adds cases on the five new 46, XX male individuals with SRY-positive and further verifies
the view that the presence of SRY gene and the absence of major regions in Y chromosome should lead to the
expectance of a completely masculinised phenotype, abnormal hormone levels and infertility.
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The 46, XX disorder of sex development (DSD) is a rare
form of sex reversal in infertile men, that was first
described by la Chapelle et al. in 1964 and occurred
1:20000 in newborn subjects [1]. By 1996, 150 patients
with classical XX male syndrome had been reported,
and more than 100 cases of this disorder have been dis-
cribed between 1996 and 2006 worldwide [2]. Clinical
phenotypes about 46, XX DSD have been identified to
three groups, including males with normal phenotype,* Correspondence: xinyixia78@gmail.com; Zhaijinshengnz@gmail.com
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unless otherwise stated.males with genital ambiguities and males with true her-
maphrodites [3]. Ovotesticular DSD, which is character-
ized by the presence of both testicular and ovarian tissue
in the gonads of the same individual, and testicular DSD
characterized by a full development of both gonads as tes-
tes without any evidence of ovarian tissue [4]. Approxi-
mately 80% of individuals with 46,XX testicular DSD
present after puberty with normal pubic hair and normal
penile size, but small testes, and sterility resulting from
azoospermia [5].
The sex-determining region Y gene (SRY) locating in Y
chromosome, plays a major role in encoding a testis deter-
mining factor (TDF) [6,7]. About 90% of these patients
have Y chromosomal material including the SRY gene, that. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of X chromosome or autosomal chromosomes. About
10% 46, XX males are negative for SRY gene, which could
carry different degrees of masculinization [8,9].
There are several pathogenic mechanisms explaining
46, XX testicular DSD patients: 1. translocation of Y se-
quences, including the SRY gene, to an X chromosome
or to an autosome; 2. a mutation in a gene in the testis-
determining pathway triggering testis differentiation in
SRY negative XX males; and 3. a hidden Y chromosome
mosaicism limited to the gonad [10].
This study aimed to describing five 46, XX male DSD
with SRY-positive, investigating the clinical characteris-
tics and their relationships with chromosomal karyotype
and the SRY gene.
Methods
Participant and Clinical data
We collected 5 untreated patients with SRY-positive 46,
XX, that were referred for infertility. The physical exam-
ination included the measurement of height, potential
gynecomastia and the inspection of external sex organs.
Bilateral volume was calculated as the sum of the volume
of both testes. According to guidelines of the World Health
Organization, semen analysis was indicated to azoospermia
after centrifugation of the ejaculate.
Serum levels of follicle-stimulating hormone (FSH),
Luteinizing Hormone (LH), Estradiol, Prolactin, testos-
terone and free testosterone were assessed.
All procedures used in the study confirmed to the tenets
of the Declaration of Helsinki. The Ethics Committee of
Jinling Hospital approved the protocols used. All partici-
pants have known to participate in the study. Written in-
formed consents were obtained from all participants.
Karyotype analysis of G-banding in lymphocytes and
Fluorescence in situ hybridization (FISH)
Karyotypes were performed on peripheral blood lympho-
cytes in five patients respectively including 100 metaphase
cells by conventional operating techniques. X chromo-
some, Y chromosome and SRY gene was located using
FISH with probes of X chromosome centromere, Y
chromosome centromere (CEP X with Spectrum Green,
CEP Y with Spectrum Orange, Vysis, Downers Grove, IL;
item no.32-111051) and SRY gene (SRY with Orange,Vysis,
Downers Grove, IL; item no.30-190079).
Molecular analysis
Genomic DNA from peripheral blood of the patients
using QIAamp DNA Blood Kits was extracted. The three
discrete regions, AZFa, AZFb and AZFc, located on the
long arm of the Y chromosome, were performed by
multiplex PCRs(Polymerase Chain Reaction) amplifica-
tion. The set of PCR primers for the diagnosis ofmicrodeletion of the AZFa, AZFb and AZFc region in-
cluded: sY84, sY86, sY127, sY134, sY254, sY255, SRY and
ZFX/ZFY.
Results
Our five patients had a lower body height. Physical
examination revealed that their testes were small in
volume, soft in texture and normal penis. No potential
gynecomastia and congenital hypospadias were seen.
And they all described that they had normal sexual func-
tion. Semen analyses showed azoospermia. Endocrino-
logical data indicated that the patients had a higher FSH,
LH level, lower free testosterone, testosterone level and
normal Estradiol, Prolactin level. General characteristics
and endocrine hormone levels are shown in Table 1.
Karyotype analysis of all patients confirmed 46, XX
karyotype, and FISH analysis showed that SRY gene were
positive and translocated to Xp (Figure 1). Molecular
analysis revealed that the SRY gene was present, and the
AZFa, AZFb and AZFc region were absent (Figure 2).
Discussion
46, XX male syndrome is a rare sex reversal syndrome
characterized by a female karyotype in discordance with
a male phenotype. 90% of 46, XX testicular DSD usually
have a normal male phenotypic heterogeneity at birth
and are diagnosed after puberty on genital ambiguities,
or infertility [8]. Our research reported that five patients
had a female karyotype but were phenotypically male
(46, XX males). They had normal external genitalia and
masculinization, but showed azoospermia. That might
be that all males were SRY-positive, which translocated
on the short arm of X chromosome, and absent of the
spermatogenic factors encoding gene on Yq, such as
AZFa, AZFb and AZFc region in Y chromosome.
SRY gene is located in the Y chromosome and encodes
a high mobility group(HMG) domain, a conserved motif
present in many DNA-binding proteins, which could
regulate testicular differentiation [11,12]. SRY protein is
expressed in the genital ridge before testis formation,
and in the testis during the period of testicular forma-
tion early in fetal life, until the development of adult
testis [13]. Molecular genetics analysis demonstrated
that most 46, XX testicular DSD patients carry SRY gene
which translocated to X chromosome [14-16]. There
was a report that an SRY gene fragment translocated
from Y chromosome to autosomal chromosome [17].
Some patients showed SRY negative, who always had ex-
ternal genital ambiguities and gynecomastia. Despite the
fact that SRY gene is considered to be the main regula-
tory factor for testis determination, phenotypic variabil-
ity showed in 46, XX sex reversed cases cannot be
explained only by whether SRY gene is presented. And a
number of other genes such as SOX9, DAX-1, WT1,
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Normal ranges ≥169 12-14 12-20 8-18 9.4-37.0 30.9-147.6 1-7 2-10 0-250 0-400
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process of gonadal differentiation [8].
The phenotype of the XX male observed in SRY posi-
tive 46,XX individuals varies greatly, from normal in-
ternal and external male gonads to abnormal secondary
sexual characteristics, small testes and hypospadias, to a
true hermaphrodite. It has been suggested that the vari-
ation in phenotype is primarily dependent on two mech-
anisms: X chromosome inactivation(XCI) pattern and
the amount of Y material including SRY gene that has
been translocated to the X chromosome [18]. Reviewing
the literature, 46,XX males with true hermaphrodites or
gonadal ambiguity have a small portion of the Y chromo-
some material translocated to the X, presumably allow-
ing for XCI spreading and inactivating the SRY gene
[19]. A normal male phenotype is expected to result
from a larger Yp SRY bearing fragment being translo-
cated to the X chromosome, where the length of the Yp
fragment may protect the SRY gene from silencing by
the spread of XCI [19]. In our study, all five cases haveFigure 1 Fluorescent in situ hybridization (FISH) on metaphase
chromosomes of second case with the LSI SRY(orange)/CEP X
(green) probes. Metaphase spread showing a normal X chromosome
(green signal for centromeric DXZ1 locus) and the SRY (orange)
translocates to the distal end of short arm of chromosome X.normal external genitalia and masculinization, which is
expected that more Y chromosome material is present
on the X, presumably protecting the SRY gene from the
spread of inactivation. Because of the unavailable in
specimens from the five cases to further study, we can-
not do more molecular analysis to confirm the above
point. Till now, both random and non-random XCI pat-
terns have been reported in 46, XX males with a normal
male phenotype [18,20]. It is indicated that the XCI pat-
tern may be not associated with the XX male phenotype.
However, another mechaniam, known as the position ef-
fect, has been reported to explain the observed phenotypic
differences. The phenotypic differences are dependent on
the proximity of the breakpoint to the SRY gene as well as
the presence or absence of cryptic rearrangements affect-
ing the expression of the SRY gene [21]. The rearrange-
ments, may result in transcriptional repression, probably
by removing essential regulatory elements or alterations of
local chromatin structure [22].
Additionly, phenotypic variability might be associated
with variations in genetic polymorphisms and copyFigure 2 Result of multiplex polymerase chain reaction (PCR).
Multiplex 1: ZFX/ZFY(690 bp), sY84 (320 bp), sY127 (274 bp); Multiplex
2: SRY (472 bp), sY86 (326 bp); Multiplex 3: sY254 (400 bp), sY134
(301 bp), sY255 (126 bp). M: DL1000 DNAMarker; W: a DNA sample
from a woman as a negative control; N: a DNA sample fro-m a normal
fertile man as a positive control; P: a DNA sample from the patient; B: a
al-ank (water) control.
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some, such as NROB1 and TAF7L [23,24].
Classical 46, XX male have normal testosterone level
and free testosterone level during adolescence, but may
decrease in adulthood, leading to hypergonadotropic
hypogonadism [25]. Our cases had normal genitalia and
were diagnosed for infertility after puberty. The level of
testosterone and free testosterone is deficiency in five
patients. In addition, high levels of FSH and LH are ob-
served. This might explain that even though the 46, XX
male have a normal external genitalia and masculinization,
and they are lack of spermatogenesis.
The body heights of the patients we reported were all
under 169 cm (the average height of Chinese male) and
close to that of normal females. There are some pheno-
typic similarities between 46,XX men and those with Kli-
nefelter syndrome, but 46,XX men tend to be shorter
than men with KS [9]. Kirsch et al. indicated that the Y
chromosome growth-control gene(GCY) which next to
the centromere had a possible impact on growth [26].
And there were some papers indicating that SHOX gene
(short stature homeobox) expression and SHOX enhan-
cer regions played a role in the growth [27]. It has been
suggested that specific growth genes in the Y chromosome
cannot switched to the patients, which might make them
to show a female stature. GH (growth hormone) therapy
may have some statural effects in the SHOX haploinsuffi-
ciency and may be insufficient to prevent the development
of skeletal lesions after puberty [28].
Conclusions
Our reports adds cases on the five new 46, XX male in-
dividuals with sex reversal and further verifies the view
that the presence of SRY gene and the absence of major
regions in Y chromosome should lead to the expectance
of a completely masculinised phenotype, abnormal hor-
mone levels and infertility.
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